drugset / Trial / NCT00273962

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

NCT00273962

Phase 4 Completed 500 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the bronchodilator efficacy of ipratropium plus salbutamol (Combivent) with salbutamol alone given every 20 minutes for three doses in asthmatic children with severe acute exacerbation

Timeline

Start
2002-05
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 500 ug
Subject Salbutamol Unknown 2.5 mg

Indications